Reuse of data sources to evaluate drug safety signals: When is it appropriate?

Shirley V. Wang*, Martin Kulldorff, Robert J. Glynn, Joshua J. Gagne, Anton Pottegård, Kenneth J. Rothman, Sebastian Schneeweiss, Alexander M. Walker

*Corresponding author for this work

    Research output: Contribution to journalComment/debateResearchpeer-review

    Original languageEnglish
    JournalPharmacoepidemiology and Drug Safety
    Issue number6
    Pages (from-to)567-569
    Publication statusPublished - Jun 2018

    Cite this